Beyond the temporary spike in demand brought on by the COVID-19 pandemic, the market for patient monitoring equipment is anticipated to expand at a moderate rate over the next few years due to an aging population, which adds to additional issues necessitating monitoring solutions. As hospitals transition to integrated monitoring solutions to enhance accessibility and analysis of patient data, improved connectivity in monitors will also be a significant growth driver for this market.

Clair Labs revolutionizes remote patient monitoring by developing breakthrough technology for the medical-grade contact-free acquisition of physiological markers. Clair Labs is shaping the future of proactive healthcare with its novel contact-free vital sensing technology. Based on breakthroughs in deep learning, computer vision, and product design, we built the holy grail of seamless monitoring.

Adi Berenson and Ran Margolin co-founded the Israel-based company in 2018 after meeting at Apple, where they were part of its product incubation group. Clair Labs was inspired by the aging population and hospital attempts to send low-acuity patients home, which led to an increase in high-acuity patients admitted to hospitals. Patients are frequently given medical equipment to use at home, and the pair reasoned that by fusing their understanding of Apple’s consumer technology with healthcare, they could make these devices more user-friendly and conducive to patients’ willingness to utilize them.

The business is initially concentrating on acute and post-acute care facilities and sleep medicine, particularly around sleep apnea. Berenson asserts that biomarker sensing is a more economical method of continuous digital monitoring. The device also records changes in the patient’s posture, such as an intention to stand up, as well as behavioral signals like sleep patterns and discomfort. Machine-learning algorithms examine all of the data to offer healthcare workers assessments and alarms. “We think the best approach is to find existing workflows and deploy our technology.” ” It is a bit trickier because you have to fall into existing clinical, regulatory, and reimbursement practices, but it works well when all of those pieces fall into place,” says Berenson.

Clair Labs is focusing on remote patient monitoring and remote healthcare businesses, both of which are predicted to experience exponential growth during an outbreak. In order to further the development of its sensors and broaden the scope of its clinical studies, Clair Labs, which is creating contact-free patient monitoring technology, announced it has secured $9 million in early investment. The system can be installed over the patient, on a wheeled column adjacent to a hospital bed, or it can be a permanent fixture installed on the ceiling over a hospital bed. Additionally, patients at home might be monitored using mobile devices.

The sensors capture photons, or light particles, released by the skin at various wavelengths, providing information on a variety of physiological indicators, including respiration, organ volume, pulse, oxygen saturation, body temperature, and others, he added. The data is incorporated into intelligent learning algorithms, which then generate precise assessments and alarms. According to the business, it accomplishes all of this without upsetting the patient or adding to the workload of caretakers.

The device also tracks changes in the patient’s position or determines when they want to stand up, as well as behavioral signals like sleep patterns or signs of discomfort. By analysing the patient’s movement, posture, and sleep habits, the goal is to go beyond the statistics and data to the patient’s overall picture of health. The remote patient monitoring and remote healthcare sectors, which are anticipated to increase rapidly during an epidemic, are the markets that Clair Labs is focusing on.

A group of machine learning and computer vision researchers, software developers, and systems engineers work at the company’s R&D facility in Tel Aviv, Israel. The money obtained will also allow the business to expand its R&D team and establish a US office. In the future, contact-free monitoring will enable remote supervision of patients during home hospitalization.